1[1]Birkedal- Hansen B, Pavelic IP, Gluckman JL, et al, MMP and TIMP gene expression in head and neck squmous cell carcinomas and adjacent tissue. Oral Dis, 2000; 6:376～382
2[2]Hara 1, Miyake H, Hara S, et al. Significance of matrix metalloproteinases and tissue inhibitors of metallopproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. J Vrol, 2001; 165:1769～1772
3[3]Yamamoto FI, Itoh F, Jku S, et al. Expression of matrix metalloproteinase and tissue inhibiitors of metalloproteinases in human pancreatic adencocearcinoma as clinicopathologic and prognostic significance of matrilysm expression. J Clin Oncol, 2000; 19: 1118～1127
4Sommerfeld HJ, McCker AK, Piatyszck MA, et al. Telomerase activity:a prevalent marker of malignant human prostate tissue. Cancer Res, 1996, 56(6):218.
5Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast turmors. J Natl Cancer Inst, 1997,89(6):437.
6Pao CC, Tseng CJ, Lin CY, et al. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasm lesions.J Clinic Oncology, 1997, 15(5): 1932.
7Kim NW, Piatyszek MA,Prowse KR, et al. Specific association of hunantelomerase activity with immortal cells and cancer. Science,1994,266(2):2011.
8Budowle B, Chakrahorty R,Glusti AM,et al. Analyiss of the VNTR lous DIS80 by PCR followed by high resolution PAGE. AM J Hum Genet, 1991 ,48(2) : 137.
9Kainz CH. Splice variants of CD44v6 in human cervical cancer stage Ⅰb to Ⅱb Gynecologic Oncology 1999, 57:383-387.
10Davidson B,Goldberg I , Kopolovic J, et al. Expression of matrix metalloproteinass - 9 in squamous cell carcinoma of the uterine cervix[J].Gynecol Oncol, 1999,72 (3) :380--386.
